WALTHAM, Mass., Sept. 27 /PRNewswire/ -- The Swedish medical technology company Astra Tech AB, a subsidiary of AstraZeneca, is purchasing the US dental company Atlantis Components Inc. for USD 71 million in cash. This business deal is part of Astra Tech's growth strategy.
"The purchase of Atlantis gives us an even stronger product portfolio in the field of dental implants. We strengthen our position in the North American market and can introduce the latest digital CAD/CAM(1) technology in Europe. This also gives us a leading position in the fastest growing segment in the field of implants," says Astra Tech's President and CEO, Peter Selley.
In the past few years, Astra Tech has grown at a rate of over 40 percent a year while the global market for dental implants has shown a growth rate of 20 percent. "Our objective is to be one of the three largest dental implant companies within the next three years," Peter Selley continues.
For the past ten years, Atlantis Components Inc. has developed a patented method for digitally producing "abutments." Using the latest CAD/CAM1 technology, individually adapted abutments are produced for each patient. As opposed to standard abutments,
Atlantis' technology is built around a unique method that is based on the appearance of the final tooth. The end result is optimized individual esthetics and long-term reliability. For the clinician and patient this technology means reduced chair time since the precision of the abutments eliminates the need for the dentist to make further adjustments. Atlantis' method makes it possible to fabricate individual abutments for most of the major implant systems on the market. The technology also allows for increased efficiency and profitability for the dental laboratory.
Atlantis Components Inc. is based in Cambridge, Massachusetts and has
100 employees. The company has had very positive growth in recent years and
now has a market-leading position in its segment. Sa
|SOURCE Astra Tech|
Copyright©2007 PR Newswire.
All rights reserved